FDA approves sleep apnea implant device

The FDA approved an implantable device, Respicardia's Remede System, which helps fight moderate to severe cases of central sleep apnea, a condition where the brain doesn't send proper signals to the muscles that control breathing during sleep.

The device consists of an implantable battery pack and thin wires that are inserted into blood vessels in the upper chest near the nerve that is responsible for sending signals to the diaphragm to fuel breathing. If the device detects the patient is not breathing, it will stimulate the nerve to move the diaphragm to initiate normal breathing.

The Remede System is not intended for use in patients who need MRI scans, have an active infection or are diagnosed with obstructive sleep apnea, a condition where the upper airway is partially or completely blocked. 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars